Structural Formula (Roc04 0003 01)
Rocuronium Injection, Solution
Product Images NDC 81565-204
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rocuronium (NDC 81565-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Phlow Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Roc04 0003 02)
Figure 2 (Roc04 0003 03)
Figure 3 (Roc04 0003 04)
Phlow Logo (Roc04 0003 05)
Vial (Roc04 0003 06)
NDC 81565-204-01 is a paralyzing agent injection. It is sterile and nonpyrogenic. The contents of the package are a multiple dose vial containing Rocuronium Bromide Injection in isotonicity with NaCl and to a pH of 4 with acetic acid and/or NaOH. Each mL contains 10 mg of rocuronium bromide and 2 mg of sodium acetate. It is used for intravenous use, and facilities must have artificial respiration immediately available as it causes respiratory arrest. The injection needs to be stored at 2° to 8°C (36° to 46°F). It should not be frozen but can be kept at room temperature for up to 60 days. However, opened vials should be used within 30 days.*
50tray (Roc04 0003 07)
This is medication information for NDC 81565-204-02, a rocuronium bromide injection used for intravenous use. The medication is sterile and nonpyrogenic, and caution should be taken as it is a paralyzing agent that can cause respiratory arrest. The usual dosage for the medication can be found in the package insert, and it should be stored at 2° to 8°C (36°F to 46°F). The medication comes in a multiple dose vial and should be used within 60 days of being removed from refrigeration. Use opened vials within 30 days. The container closure is not made with natural rubber latex. Rocuronium bromide is the active ingredient in the medication, with 10 mg per mL of medication.*
Package Label (PRINCIPAL DISPLAY)
This is a description of a pharmaceutical product called "Rocuronium Bromide Injection". It is a paralyzing agent which is administered intravenously with a recommended dose of 10 mg per mL. The label implies that the product is only available with a prescription (Rx only) and the instructions indicate that the medication should be applied after peeling off something. The text also includes a timestamp, but without additional context, it is not clear what the purpose of this timestamp is.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
